about
Q27908387-0B455364-EBB3-4AB1-ADCF-0C6C6A7E4C4FQ27908387-186093CE-B19D-4F62-9C22-33E98242CD97Q27908387-23F3F50D-07D7-4600-AD11-4029CB85FFE8Q27908387-4FF6BC5B-E3DE-4F27-BFCE-882EE57634E2Q27908387-85FEF060-FF64-4FD4-929D-D49243D20066Q27908387-DCA93064-98CE-4F68-8F9D-5B005FE6875FQ27908387-ED44354E-195A-4C02-ADC2-93AD640C8D1CQ28445204-EA6CDBE4-9918-4165-928D-41F4B64FA797
P3354
description
combination therapy
@en
name
Pertuzumab / Trastuzumab combination therapy
@en
type
label
Pertuzumab / Trastuzumab combination therapy
@en
prefLabel
Pertuzumab / Trastuzumab combination therapy
@en